Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
gynostemma pentaphyllum total glycoside granules
- Development stage
- Unknown
- Lead developer
- Changzhou Sports Hospital
- Administration
- Oral
01
Overview
Gynostemma pentaphyllum total glycoside granules are a botanical drug product derived from the herb *Gynostemma pentaphyllum* (Jiaogulan). The primary active components are gypenosides, which are dammarane-type saponins structurally similar to ginsenosides. These glycosides are known to activate adenosine monophosphate-activated protein kinase (AMPK), a key regulator of lipid and glucose metabolism. In clinical settings, particularly in China, it is used to treat dyslipidemia and non-alcoholic fatty liver disease (NAFLD) by lowering non-HDL cholesterol and triglycerides while improving cardiovascular function. The granule formulation is intended for oral administration and is often studied in combination with lifestyle interventions like scientific exercise.
- Other names
- GypenosidesGynostemma pentaphyllum total saponinsJiaogulan total glycoside granules
02
Targets
FOXO1 (Forkhead box protein O1)mTOR (Mammalian target of rapamycin kinase)AMPK (Adenosine monophosphate–activated protein kinase)NF-κBCACNA1C (Voltage-dependent L-type calcium channel subunit alpha-1C)KATP channel (ATP-sensitive potassium channel)SIRT1 (NAD-dependent protein deacetylase sirtuin-1)RK (Ribokinase)PPARGC1A (Peroxisome proliferator–activated receptor gamma coactivator 1-alpha)
Beyond the preview
Go deeper on gynostemma pentaphyllum total glycoside granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on gynostemma pentaphyllum total glycoside granules.